Physician profile
James S Fix
NPI 1164429411
$949.54
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $55.39 · 2021: $119 · 2022: $66.06 · 2023: $127 · 2024: $115 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $226.85 | 2019-2025 | Tendril, Diamondback Coronary, Cardiomems |
| Medtronic, INC. | $117.77 | 2024-2025 | Corevalve Evolut R, Onyx Frontier |
| Pfizer INC. | $102.58 | 2022-2025 | |
| Boston Scientific Corporation | $94.11 | 2019-2025 | Avvigo Guidance System |
| Cardiovascular Systems INC. | $73.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $39.52 | 2020-2021 | |
| Medtronic Vascular, INC. | $38.32 | 2019-2020 | |
| Shockwave Medical, INC | $38.14 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $37.26 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Janssen Pharmaceuticals, INC | $36.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.47 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $27.71 | 2023 | Farxiga |
| Biotronik INC. | $26.38 | 2019 | |
| Chiesi USA, INC. | $23.95 | 2021 | |
| Edwards Lifesciences Corporation | $23.86 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $14.14 | 2023 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.